Expression of a tumor-associated gene, LASS2, in the human bladder carcinoma cell lines BIU-87, T24, EJ and EJ-M3
- PMID: 23407876
- PMCID: PMC3570257
- DOI: 10.3892/etm.2013.892
Expression of a tumor-associated gene, LASS2, in the human bladder carcinoma cell lines BIU-87, T24, EJ and EJ-M3
Abstract
Homo sapiens longevity assurance homolog 2 of yeast LAG1 (LASS2), a metastasis suppressor gene of human cancer, is the most abundantly expressed member of the ceramide synthase gene family. Expression of LASS2 has been reported in carcinomas of the prostate, liver and breast. However, there has been no report on the expression of LASS2 in human bladder cancer cell lines. In order to investigate the expression and potential role of this new tumor metastasis supressor gene in human bladder cancer, we compared the proliferation, metastasis and invasion among the BIU-87, T24, EJ and EJ-M3 human bladder cancer cell lines. The mRNA expression levels of the LASS2 gene were examined using real-time quantitative PCR (qPCR). The expression levels of LASS1 and LASS3 mRNA were used as references. The protein expression level of the LASS2 gene was detected using western blotting. The most aggressive of these four human cancer cell lines was observed to be EJ-M3. The expression of LASS2 mRNA was significantly correlated with diverse proliferation, metastasis and invasion. The expression levels of LASS1 and LASS3 mRNA were not correlated with these parameters. At the protein level, we observed that the more aggressive the cancer cell line, the lower the LASS2 protein expression level. Therefore, LASS2 expression may be correlated with the development and progression of human bladder cancer and may be a prognostic indicator for this cancer.
Keywords: Homo sapiens longevity assurance homolog 2 of yeast LAG1; biological characteristics; bladder cancer; expression.
Figures
References
-
- Morgan TM, Keegan KA, Clark PE. Bladder cancer. Curr Opin Oncol. 2011;23:275–282. - PubMed
-
- Saffar H, Sanii S, Heshmat R, et al. Expression of galectin-3, nm-23, and cyclooxygenase-2 could potentially discriminate between benign and malignant pheochromocytoma. Am J Clin Pathol. 2011;135:454–460. - PubMed
-
- Kim SH, Lee SY, Park HR, et al. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Cancer. 2011;117:1864–1873. - PubMed
-
- Polanski R, Maguire M, Nield PC, et al. MDM2 interacts with NME2 (non-metastatic cells 2, protein), and suppresses the ability of NME2 to negatively regulate cell motility. Carcinogenesis. 2011;32:1133–1142. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases